Marjorie Bateman1, Upendra Kaphle2, Jaime Palomino3, Nadja Falk4, Fayez Kheir5. 1. Department of Medicine, Tulane University School of Medicine, New Orleans, LA. 2. Division of Pulmonary and Critical Care, Kaiser Permanente Roseville and Sacramento Medical Center, Roseville, CA. 3. Division of Pulmonary, Critical Care and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA; Southeast Louisiana Veterans Healthcare System, New Orleans, LA. 4. Division of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM. 5. Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Boston, MA. Electronic address: fkheir@bidmc.harvard.edu.
Abstract
CASE PRESENTATION: A 54-year-old man presented with 6 months' history of dry cough and dyspnea on exertion. He also reported intermittent joint pain and orthopnea. He denied fevers, chills, and rashes. His medical history was significant for rheumatoid arthritis, for which he was taking 20 mg of prednisone daily. He had not been receiving adalimumab or methotrexate for several months. He never smoked and drank alcohol occasionally. Family history was significant for rheumatoid arthritis.
CASE PRESENTATION: A 54-year-old man presented with 6 months' history of dry cough and dyspnea on exertion. He also reported intermittent joint pain and orthopnea. He denied fevers, chills, and rashes. His medical history was significant for rheumatoid arthritis, for which he was taking 20 mg of prednisone daily. He had not been receiving adalimumab or methotrexate for several months. He never smoked and drank alcohol occasionally. Family history was significant for rheumatoid arthritis.